The tolerogenic function of annexins on apoptotic cells is mediated by the annexin core domain

B Linke, L Abeler-Dörner, V Jahndel, A Kurz… - The Journal of …, 2015 - journals.aai.org
B Linke, L Abeler-Dörner, V Jahndel, A Kurz, A Mahr, S Pfrang, L Linke, PH Krammer…
The Journal of Immunology, 2015journals.aai.org
Immunological tolerance is constantly being maintained in the periphery by dendritic cells
processing material from apoptotic cells (ACs) in the steady-state. Although research has
focused on the uptake of ACs by phagocytes, tolerogenic signals exposed by the ACs are
much less well defined. In this article, we show that the annexin (Anx) family members
AnxA5 and AnxA13 translocate to the surface of ACs to function as redundant tolerogenic
signals in vitro and in vivo. Exposure of bone marrow–derived dendritic cells to AnxA5 or …
Abstract
Immunological tolerance is constantly being maintained in the periphery by dendritic cells processing material from apoptotic cells (ACs) in the steady-state. Although research has focused on the uptake of ACs by phagocytes, tolerogenic signals exposed by the ACs are much less well defined. In this article, we show that the annexin (Anx) family members AnxA5 and AnxA13 translocate to the surface of ACs to function as redundant tolerogenic signals in vitro and in vivo. Exposure of bone marrow–derived dendritic cells to AnxA5 or AnxA13 in vitro resulted in the inhibition of both proinflammatory cytokine secretion and the upregulation of costimulatory molecules upon TLR stimulation. The highly conserved Anx core domain was sufficient to mediate these effects, whereas recognition by N-formyl peptide receptor family members was dispensable. In vivo, coinjection of OVA-expressing and Anx-expressing ACs prevented induction of Ag-specific CD8+ T cells. Moreover, mice immunized with Anx-expressing ACs became refractory to an antigenic challenge. These results suggest that several Anxs contribute to AC-induced suppression of dendritic cell activation. Therefore, manipulating Anx-mediated immunosuppression may prove beneficial for patients with cancer or autoimmune diseases and chronic inflammatory disorders.
journals.aai.org